United States · FDA National Drug Code directory
CYCLOBENZAPRINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-4729_44f75da3-1fee-4928-b8eb-491d47d8bc08
- Product NDC
- 50090-4729
- Form
- TABLET, FILM COATED
- Composition / generic term
- cyclobenzaprine hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170531
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 TABLET, FILM COATED in 1 BOTTLE (50090-4729-0) · 50090-4729-0
- 12 TABLET, FILM COATED in 1 BOTTLE (50090-4729-1) · 50090-4729-1
- 42 TABLET, FILM COATED in 1 BOTTLE (50090-4729-4) · 50090-4729-4
- 6 TABLET, FILM COATED in 1 BOTTLE (50090-4729-8) · 50090-4729-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →